Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Phoenix | 8,268 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,268 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3561-3580 of 8,268 trials

Active not recruitingAn Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 StudyThe purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and…NCT06534892·Birmingham, Alabama and 250 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaThis randomized phase III trial studies rituximab with bendamustine hydrochloride or ibrutinib to see how well they work compared to ibrutinib alone in treating older patients…NCT01886872·Birmingham, Alabama and 936 others

Active not recruitingEvaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightThe primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.NCT06858839·Anniston, Alabama and 242 others

CompletedSafety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)This clinical trial is designed to provide additional information on the safety and tolerability of vildagliptin (50 mg once daily (qd)) and sitagliptin (25 mg qd) when used in…NCT00770081·Mobile, Alabama and 86 others

Active not recruitingA Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosisNCT06564311·Cullman, Alabama and 46 others

Active not recruitingA Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab per intravenous (IV) infusion…NCT04548999·Homewood, Alabama and 146 others

TerminatedA Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)For participants enrolled prior to Version 6 of the protocol: This was a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study…NCT02901431·Dothan, Alabama and 44 others

CompletedEtrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisThe purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for moderately active ulcerative colitis in adult participants.NCT04607837·Dothan, Alabama and 287 others

CompletedSafety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal WomenThis study is a randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of LibiGel 300mcg in the treatment of HSDD in surgically menopausal…NCT00657501·Mobile, Alabama and 68 others

CompletedSWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002900·Mobile, Alabama and 104 others

CompletedUse of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb IschemiaThis study is designed to evaluate the safety and efficacy of autologous Vascular Repair Cells (VRC) for patients with peripheral arterial disease as a treatment for critical limb…NCT00468000·Birmingham, Alabama and 19 others

CompletedComparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineThe study is being conducted to evaluate two doses of TEV-48125 in adult patients with chronic migraineNCT02621931·Birmingham, Alabama and 272 others

TerminatedA 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire DisorderTo generate additional long-term safety and efficacy data on flibanserin in premenopausal women and establish long-term safety and tolerability of flibanserin in naturally…NCT01103362·Birmingham, Alabama and 94 others

RecruitingFabry Disease Registry & Pregnancy Sub-registryThe Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease…NCT00196742·Birmingham, Alabama and 283 others

CompletedRandomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneTo compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early…NCT00036270·Bessemer, Alabama and 178 others

CompletedLong-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic PainThis Phase 3, multi-center study will evaluate the long-term safety and tolerability of hydrocodone bitartrate controlled release capsule (HC-CR) at daily doses of 40 mg or more…NCT01115569·Phoenix, Arizona and 49 others

CompletedOpen Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia GravisThe purpose of this study is to determine whether Hizentra is a safe and effective treatment for people with myasthenia gravis (MG).NCT02100969·Phoenix, Arizona and 4 others

CompletedCan TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to CimziaPurpose of the study is to determine if Cimzia is safe and effective in subjects who have received previous treatment with a TNF-alpha inhibitor other than Cimzia.NCT01147341·Huntsville, Alabama and 11 others

CompletedAdvance Cardiac Resynchronization Therapy (CRT) RegistryThe intent of this registry is to understand comprehensive clinical care strategies for Cardiac Resynchronization Therapy (CRT) patients especially non-responders in real-world…NCT01805154·Birmingham, Alabama and 68 others

CompletedDose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal CandidiasisThis is a multicenter, randomized, double-blind, double-dummy, active-controlled, dose-finding study to compare the efficacy, safety and tolerability of oral SCY-078 versus oral…NCT03253094·Birmingham, Alabama and 24 others

PreviousPage 179 of 414Next

in Phoenix

Heart Diseasein Phoenix